Melico Sciences Ltd has received a large funding boost from a private investor with legal support from JLF’s mergers and acquisitions lawyers.
Melico uses a tiny drop of an individual’s urine to produce a metabolic ‘fingerprint’. The company’s scientists then analyse the data in the individual’s metabolism to create a diet and exercise plan that is perfect for their personal physiology and chemistry.
The funding injection will accelerate Melico’s growth and provide jobs and investment to the city of London.
Lead partner Jabad Jaigirdar said, “Transactions in the life sciences space tend to be highly complex and their success hinges on deep industry knowledge. We’re therefore honoured to advise our client Melico Sciences Ltd and to have played a part in securing this investment.”